Skip to main content
U.S. flag

An official website of the United States government

Showing 1-10 of 670

Show
Rear Adm. Matthew Case, Defense Health Agency acting deputy director, and Sgt. Maj. Manuel Cruz, DHA senior enlisted leader, health care administration, host an employee recognition ceremony January 20 at Defense Health Headquarters in Falls Church, Virginia. Honorees included Cmdr. Raben Talvo, Lt. j.g. Brandon Andriot, and Sven Perryman.

Recognizing employee excellence that carries ‘the legacy of military medicine’

Feb. 04, 2026

The ceremony recognized the exceptional work of service members and civilians and those earning Continuous Process Improvement certifications.


The Centers for Disease Control and Prevention issued a nationwide Health Alert Network Health Advisory on January 20 to share information about the New World screwworm and the recent increase in animal cases in the Mexican state of Tamaulipas, which shares a border with Texas. NWS is a parasitic fly whose larvae feed on the living tissue of warm-blooded animals, including dogs, livestock, wildlife, and, rarely, humans. Female flies lay eggs in open wounds or moist body openings; within about a day the larvae hatch and begin burrowing into healthy tissue, causing painful, rapidly worsening wounds if not treated promptly. (Defense Health Agency-Public Health graphic illustration by Rachel Stershic).

CDC issues nationwide health advisory on New World screwworm

Feb. 02, 2026

The CDC issued a nationwide health alert Network Health Advisory to share information about the New World screwworm.


Megan Dunkle, Forensic Toxicology method development analytical toxicologist 2, adds an organic chemical in a drop-wise fashion to precipitate blood proteins out of a solution, in the extractions laboratory of the FORTOX division of the Armed Forces Medical Examiner System, Dover Air Force Base, Delaware, Jan. 13, 2026.

Forensic toxicology reinforces joint standards

Jan. 30, 2026

AFMES’ Forensic Toxicology division runs and maintains the DOW’s only American Board of Forensic Toxicology International Organization for Standardization accredited laboratories.


U.S. Army Col. Richard Clark, chief nursing officer at William Beaumont Army Medical Center, presents Arianna Bordanada, vascular access registered nurse at WBAMC, with the WBAMC Light The Way Nurse Award on Jan. 15, 2026, at the main campus of the hospital.

Nurse receives prestigious WBAMC award

Jan. 29, 2026

The Light the Way award was re-ignited last year to celebrate nurses within the organization.


The 2026 Senior Leader Forum, co-hosted hosted by Medical Readiness Command, Europe (MRCE) and Defense Health Network Europe (DHN-E), brought together senior military medical leaders from all branches of service across the European theater.

U.S. Military senior medical leaders from across Europe take part in senior leader forum

Jan. 27, 2026

The three-day event aimed to operationalize data for medical organizations operating in, and supporting, the USEUCOM and USAFRICOM areas of responsibility.


A prototype Freeze-Dried Plasma transfusion kit sits on display, Fort Detrick, Md., Jan. 21, 2026. Blood replacement therapies are a top-tier priority for the Joint Services and U.S. Combatant Commands. FDP, managed by the Defense Health Agency’s Operational Medical Systems Program Management Office, is a shelf-stable plasma designed for use in far-forward environments, potentially saving lives during future conflicts by enabling quicker access to this vital resource while simultaneously easing the logistical burden of transporting traditional blood products. OPMED’s Warfighter Protection and Acute Care Project Management team, in partnership with stakeholders across the Department of War and development industry, have worked to increase commercial availability of FDP during the past several years to fill critical capability gaps for frontline medical providers as they prepare for future conflicts in remote, austere environments like the Indo-Pacific and Arctic regions of the globe. As part of DHA, OPMED partners with stakeholders across the Joint Force to develop, acquire, and field medical devices, treatments, and frontline care solutions for military medical providers to fill capability gaps with the speed of relevance. (Defense Health Agency Photo by Cameron E. Parks/Released)

Freeze-dried plasma meets needs of Joint Force, Combatant Commands for future conflicts

Jan. 26, 2026

Most of WPAC’s efforts centers on delivering blood products to fill existing capability gaps for frontline providers across the Department of War.


Did you know we have a Patient Advocate to serve as your go-to resource for concerns or questions about health care services received at Madigan? (Pictured: Madigan's Patient Experience team, picture from left to right, Madigan’s Patient Experience (PXO) Team: Ms. Edilene Del Valle, Mr. Gregory Williams, Ms. Theresa Manuel, and Mr. Jeremy O’Bryan. Photo courtesy of Madigan PXO team)

DHA launches Patient Advocate Assistance Reporting Tool to ‘make sure that our patients’ voices are being heard’

Jan. 23, 2026

The primary goal of PAART is to use patient feedback provided to drive improvements within military hospitals and clinics.


An Airman wears a continuous positive-air pressure mask in the 673d Medical Group Sleep Disorder Clinic at the Joint Base Elmendorf-Richardson Hospital, Alaska, Oct. 30, 2015. The CPAP is the primary tool to prevent chronic sleep apnea by keeping the airway open and stop snoring. (U.S. Air Force photo by Airman 1st Class Christopher R. Morales)

New clinical practice guideline recognizes insomnia and sleep apnea can occur together

Jan. 22, 2026

The CPGs are designed to help primary care health professionals use the most up-to-date and evidence-based disease identification and treatment options.


Smiling man and woman at a beach, taking a selfie

Retirement changes your TRICARE coverage: Learn what to do if you’re retiring in 2026

Jan. 22, 2026

When you retire from active duty or the National Guard or Reserve, you experience a TRICARE Qualifying Life Event.


Christina Gardner, Ph.D., a contract scientist with Chenega, Cherokee Nation Integrated Health, LLC working in USAMRIID’s Viral Pathogenesis Branch, performs a neutralization assay in a biosafety level 3 (BSL-3) laboratory. Gardner is the lead author on the joint study that has identified two promising single-domain antibodies (sdAbs) that may offer a therapeutic option against multiple subtypes of Venezuelan equine encephalitis virus (VEEV).

USAMRIID collective study demonstrates potential broad-spectrum anti-alphavirus therapeutics

Jan. 21, 2026

A mosquito-borne alphavirus, VEEV can cause a spectrum of disease from mild febrile flu-like illness to neurological symptoms in 4%–14% of infected individuals.